Human trial
Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients.
114 postoperative bowel-resection patients analyzed
Reported findings. No efficacy advantage established
Nonresponse. Primary endpoint difference not significant
Harms. Adverse events frequent in both arms
Limits. No transfer to other routes/formulations/indications; clinician review pending.
Preparation: IV ipamorelin trial preparation Route: intravenous
Read original source ↗Editorial review 2026-10-09. Clinician review pending.